Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal recessive form of PXE.
Features include always present findings: Retinal peau d'orange; and very common findings: Angioid streaks of the fundus. 26 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 9 | Stroke, Restrictive cardiomyopathy, Angina pectoris |
Eyes | 6 | Optic disc drusen, Retinal peau d'orange, Angioid streaks of the fundus |
Brain and nerves | 1 | Stroke |
Digestive system | 1 | Gastrointestinal hemorrhage |
Skin | 1 | Yellow papule |
Age of onset: adulthood, middle age, adolescence.
Pseudoxanthoma elasticum (PXE) is a systemic disorder that affects the elastic tissue of the skin, the eye, and the cardiovascular and gastrointestinal systems. Individuals can present as early as age five years with papules in the skin and/or between ages ten and 30 years with angioid streaks of the retina found on routine eye examination or associated with retinal hemorrhage. Manifestations of other vascular involvement include gastrointestinal angina and/or bleeding, intermittent claudication of arm and leg muscles, stroke, and renovascular hypertension, especially at an unexpectedly young age. Table 2. Select Features of Pseudoxanthoma Elasticum (PXE)
Feature | % of Personswith Feature | Comment |
|---|---|---|
Skin lesions | 100% | In advanced stages, skin can become lax redundant; sometimes reconstructive surgery is necessary. |
Retinal involvement |
ABCC6 encodes ATP binding cassette subfamily C member 6 (1,503 aa). ATP-dependent transporter of the ATP-binding cassette (ABC) family that actively extrudes physiological compounds, and xenobiotics from cells. Highest expression in Liver (40.8 TPM) and Kidney Cortex (6.5 TPM).
Autosomal recessive inherited pseudoxanthoma elasticum is associated with mutations in the ABCC6 gene on chromosome 16.
The ABCC6 protein participates in Defective ABCC6 causes PXE and Defective ABCC6 does not transport organic anion from cytosol to extracellular region pathways.
ABCC6 is classified as a druggable target (Abc Transporter, Druggable Genome, and Transporter categories) with score 0.9.
256 pathogenic variants reported in ABCC6 in ClinVar, including hotspot variants LRG_1115p1:p.Arg1141Ter (2-star review) and 6560 (2-star review).
Variant | Significance | Review Stars | Hotspot |
|---|---|---|---|
LRG_1115p1:p.Arg1141Ter | Pathogenic | 2 stars | Yes |
6560 | Pathogenic | 2 stars | Yes |
LRG_1115p1:p.Arg391Gly | Conflicting interpretations of pathogenicity | 1 stars | Yes |
No clinically relevant genotype-phenotype correlations for ABCC6 have been identified. In addition, the phenotype does not differ between individuals with biallelic ABCC6 pathogenic variants and those who meet clinical diagnostic criteria but who do not have a known genetic cause.
Source: GeneReviews — "Pseudoxanthoma Elasticum"
Formal diagnostic criteria for pseudoxanthoma elasticum (PXE) have been established .
PXE should be suspected in individuals with the following clinical findings and family history.
Clinical findings
• Skin
Papules (darker than the skin color), usually seen on the lateral aspect of the neck or the flexural creases, such as the antecubital fossae, axillae, groin, or popliteal fossae
Plaques formed by coalescence of papules
Loose, slack, or droopy, redundant skin (especially of the neck, axilla, and groin) that occurs with time
• Eye
Source: GeneReviews — "Pseudoxanthoma Elasticum"
Hereditary Disorders Table 3. Genes of Interest in the Differential Diagnosis of Pseudoxanthoma Elasticum (PXE)
Gene(s) | Disorder | MOI | Clinical Features Overlapping w/PXE | Differentiating Features |
|---|---|---|---|---|
PYCR1 | Cutis laxa | ARAD | Loose sagging skin mimicking PXE; no discrete papules or plaques | Skin lesions appear over the entire body; in PXE they are limited to the flexor areas. |
Genetic testing for ABCC6 is available. Testing is considered confirmatory for diagnosis.
No approved treatments are currently available for autosomal recessive inherited pseudoxanthoma elasticum. An additional 1 compound holds orphan drug designation.
While no drugs are FDA-approved specifically for autosomal recessive inherited pseudoxanthoma elasticum, some of the following designated compounds may be used off-label in clinical practice. Treatment decisions should be made in consultation with a specialist familiar with this condition.
The following drugs have received orphan drug designation from the FDA for autosomal recessive inherited pseudoxanthoma elasticum. Orphan designation reflects regulatory interest and does not indicate approval for treatment.
Brand Name | Generic Name | Sponsor | Designated | Exclusivity End | Designation Status |
|---|---|---|---|---|---|
a small molecule tissue-nonspecific alkaline phosphatase inhibitor | a small molecule tissue-nonspecific alkaline phosphatase inhibitor | Daiichi Sankyo, Inc. | 2019 | — | Designated |
Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with pseudoxanthoma elasticum (PXE), the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 4. Recommended Evaluations Following Initial Diagnosis in Individuals with Pseudoxanthoma Elasticum (PXE)
System/Concern | Evaluation | Comment |
|---|---|---|
Skin | Complete skin exam w/biopsy (if not done previously) by dermatologist | To establish a baseline |
Eye | Complete exam by retinal specialist incl best corrected visual acuity, Amsler grid, OCT,1 retinal exam for neovascularization macular atrophy |
Racquet and contact sports carry an increased risk for ocular and head trauma, both of which have been reported to precipitate retinal hemorrhage in patients with angioid streaks; participation in such activities should be discouraged. Individuals with PXE who participate in sports and physical recreation should wear appropriate protective eyewear such as polycarbonate sports goggles and/or protective helmets with eye shields. Aspirin and nonsteroidal anti-inflammatory medications should be avoided whenever possible to reduce the risk of gastrointestinal bleeding. Smoking is strongly discouraged because of its vasoconstrictive properties.
Source: GeneReviews — "Pseudoxanthoma Elasticum"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Pseudoxanthoma Elasticum"
9 trials found
Table 6. Recommended Surveillance for Individuals with Pseudoxanthoma Elasticum (PXE)
System/Concern | Evaluation | Frequency |
|---|---|---|
Skin | Consultation w/cosmetic dermatologist or reconstructive surgeon if redundant skin presents risk of infection | Per patient |
Eye | Retinal exam by retinal specialist | Annually or more frequently per treating ophthalmologist when retinal neovascularization is active /or treatment is ongoing Patient use of Amsler grid to monitor for central visual disturbances |
Gastrointestinal | Per treating gastroenterologist | Per treating gastroenterologist Vascular |
/or arm muscles | Per treating vascular clinic/surgeon | Per treating vascular clinic/surgeon |
Stroke | Per treating stroke clinic/neurologist | Per treating stroke clinic/neurologist Renovascular |
hypertension | Per treating nephrologist | Per treating nephrologist Cardiovascular complications |
angina, MI) | Per treating cardiologist | Per treating cardiologist MI = myocardial infarction |
Source: GeneReviews — "Pseudoxanthoma Elasticum"
Phenotype severity distribution: 1 always present feature, 1 very common feature, 6 common features.
Estimated prevalence: 1-9 in 100,000 (Uncommon).
9 clinical trials registered, 6 recruiting. Interventions under study include other interventions, drug therapy, procedural interventions, and biologic therapy. Pipeline includes 1 PHASE3, 1 PHASE2, 1 PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT05662085](https://clinicaltrials.gov/study/NCT05662085) | Progression Rate of Pseudoxanthoma Elasticum-associated Choroidal and Retinal Degeneration | — | University Hospital, Basel, Switzerland | ACTIVE_NOT_RECRUITING |
[NCT06636344](https://clinicaltrials.gov/study/NCT06636344) | Impact of Optimized Recruitment and Follow-up of Patients With Pseudoxanthoma Elasticum (PXE) | — | University Hospital, Angers | RECRUITING |
[NCT04868578](https://clinicaltrials.gov/study/NCT04868578) | PPI Supplementation to Fight ECtopIc Calcification in PXE | NA | Centre Hospitalier Universitaire de Nice | RECRUITING |
[NCT06462547](https://clinicaltrials.gov/study/NCT06462547) | ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency | PHASE2 | Inozyme Pharma | ACTIVE_NOT_RECRUITING |
[NCT05832580](https://clinicaltrials.gov/study/NCT05832580) | The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum | PHASE3 | UMC Utrecht | RECRUITING |
11 publications have been identified in PubMed for autosomal recessive inherited pseudoxanthoma elasticum. Research spans Case Report / Case Series (30%), Basic Science / Preclinical (30%), and Review / Meta-Analysis (20%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 3 | 30% |
Laboratory research | 3 | 30% |
Research summaries | 2 | 20% |
Clinical study results | 1 | 10% |
Disease patterns and progression | 1 | 10% |
Rajpar I (2026). [PMID: 41631202](https://pubmed.ncbi.nlm.nih.gov/41631202/). *JBMR Plus*. [Basic Science / Preclinical]
Liang L (2026). [PMID: 41552733](https://pubmed.ncbi.nlm.nih.gov/41552733/). *Cureus*. [Case Report / Case Series]
Rajpar I (2025). [PMID: 40777294](https://pubmed.ncbi.nlm.nih.gov/40777294/). *bioRxiv*. [Basic Science / Preclinical]
Harmsen IM (2025). [PMID: 41131563](https://pubmed.ncbi.nlm.nih.gov/41131563/). *Trials*. [Clinical Trial Publication]
Mesquita R (2025). [PMID: 40725401](https://pubmed.ncbi.nlm.nih.gov/40725401/). *Genes (Basel)*. [Epidemiology / Natural History]
Wakasa M (2025). [PMID: 40226385](https://pubmed.ncbi.nlm.nih.gov/40226385/). *Atheroscler Plus*. [Case Report / Case Series]
Pfau K (2024). [PMID: 38815804](https://pubmed.ncbi.nlm.nih.gov/38815804/). *Prog Retin Eye Res*. [Review / Meta-Analysis]
Dangreau L (2024). [PMID: 39329949](https://pubmed.ncbi.nlm.nih.gov/39329949/). *Curr Issues Mol Biol*. [Case Report / Case Series]
Ghaoui N (2024). [PMID: 39090009](https://pubmed.ncbi.nlm.nih.gov/39090009/). *Skinmed*. [Review / Meta-Analysis]
Viheriälä T (2024). [PMID: 39347541](https://pubmed.ncbi.nlm.nih.gov/39347541/). *J Ophthalmol*. [Basic Science / Preclinical]
Data assembled from 10 of 12 sources · Last updated Sep 19, 2026, 6:58 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
100% |
Subretinal neovascularization w/hemorrhage can cause significant visual impairment. |
Vascular (arterialarrowing) | 60% | Can cause claudication, small strokes, intestinal angina, renovascular hypertension, angina /or myocardial infarction |
GI bleeding | 10% | Most commonly in the upper GI tract Based on Skin. Skin lesions are generally the first sign and are present between the first and second decade of life, but are often not recognized as a sign of PXE. The primary skin lesion is a papule that is somewhat darker than the person's natural skin tone, i. |
Source: GeneReviews — "Pseudoxanthoma Elasticum"
ENPP1 |
Generalized arterial calcification of infancy (GACI) |
AR |
Severe arteriopathy; Children w/GACI may also develop the typical cutaneous ocular phenotype of PXE.1 |
GACI is very severe in children; PXE is very mild often not apparent in childhood. FGF23 GALNT3 KL |
Hyperphosphatemic familial tumoral calcinosis | AR | Angioid streaks in the retina2 | Skin lesions are present in PXE. | — |
GGCX | PXE-like disorder w/multiple coagulation factor deficiency (OMIM 610842) | AR | Cutis laxa-like skin changes w/histolopathologic changes of PXE deficiency of vitamin K-dependent clotting factors | No issues w/clotting in PXE HBB |
Beta-thalassemia | AR | PXE-like phenotype (skin, eye [angioid streaks in the retina2], cardiovascular) | Although similar, the angioid streaks are not concurrent w/skin lesions. | — |
HBB | Sickle thalassemia (See Sickle Cell Disease.) | AR | Angioid streaks in the retina2 | Although similar, the angioid streaks are not concurrent w/skin lesions. |
LEMD3 | Buschke-Ollendorf syndrome (BOS) (OMIM 166700) | AD | Osteopoikilosis assoc w/cutaneous papules w/accumulation of elastin in dermis | On skin biopsy, PXE does not have the same extent of abnormal collagen fibers near the calcified elastic fibers.; The skin lesions in BOS do not calcify histopathologically.; No osteopoikilosis in PXE PDB4 SQSTM1 TNFRSF11A TNFRSF11B |
ZNF687 | Paget disease of bone (OMIM PS167250) | ADAR | Angioid streaks in the retina2 | No skin lesions in Paget disease of bone AD = autosomal dominant; AR = autosomal recessive; MOI = mode of inheritance 1. 2. |
Source: GeneReviews — "Pseudoxanthoma Elasticum"
Reduced vision | Consultation w/agencies for the visually impaired1 | Use of low vision aids2 |
Gastrointestinal (bleeding, angina) | Obtain past medical history medical records for findings consistent w/these potential complications | Referral to gastroenterologist Vascular |
/or arm muscles | Obtain past medical history medical records for findings consistent w/these potential vascular complications | Referral to vascular clinic Stroke |
Cardiovascular assessment | Referral to cardiologist for baseline exam | Cardiovascular issues (if present) may be exacerbated by PXE. |
Other | Consultation w/clinical geneticist /or genetic counselor | OCT = optical coherence tomography In the US, publicly funded agencies at the state level provide services for the blind or those with progressive eye disorders; services include vocational training, mobility training, and skills for independent living. |
Treatment of Manifestations in Individuals with Pseudoxanthoma Elasticum (PXE) System/Concern | Treatment | Considerations/Other |
Skin | Reconstructive surgery1 | Reconstructive surgery may be indicated to improve skin changes of the face, neck, axilla, groin that are causing infection inflammation. |
Eye | Current treatment for macular neovascularization, incl intravitreal injection of anti-angiogenic drugs2 | Consult a retinal specialist immediately for any distortion in vision or in visual acuity. |
Gastrointestinal | Surgical intervention may be indicated for Gl bleeding.3 | Avoid use of aspirin NSAIDs to risk of GI bleeding. Vascular |
/or arm muscles | Per treating vascular clinic/surgeon4 | — |
Stroke | Per treating stroke clinic/neurologist | Renovascular |
hypertension | Per treating nephrologist4 | Cardiovascular complications |
(angina, MI) | Mgmt of angina /or prior MI per treating cardiologist/cardiovascular surgeon5 | GI = gastrointestinal; MI = myocardial infarction; NSAIDs = nonsteroidal anti-inflammatory drugs 1. As directed by a dermatologist or plastic surgeon 2. , 3. Bleeding may be difficult to control without surgery . 4. |
Source: GeneReviews — "Pseudoxanthoma Elasticum"